Organization and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2018

Accounting Policies [Abstract]

Contract Assets and Liabilities

The following table reflects the Company’s contract assets and contract liabilities:

	December 31, 2018		December 31, 2017
	(In thousands)
Short-term unbilled receivables - included in accounts receivable and unbilled receivables	$	9,191	$	4,590
Long-term unbilled receivables - included in other long-term assets	16,481		9,475
Total contract assets	$	25,672	$	14,065
Short-term deferred revenues, net	$	81,835	$	78,774
Long-term deferred revenues	10,582		10,623
Total contract liabilities	$	92,417	$	89,397

Property and Equipment

Depreciation and amortization is computed by use of the straight-line method over the estimated useful lives of the assets as stated below:

Computer equipment and related software	3 - 5 years
Leasehold and building improvements	Shorter of the lease term or the estimated useful life
Furniture and fixtures	5 - 7 years
Equipment	3 - 12 years

Schedule of New Accounting Pronouncements and Changes in Accounting Principles

Adoption of the standard related to revenue recognition impacted the Company’s reported results as follows:

	Year Ended December 31, 2017
	As Reported			Adjustment			As Adjusted
	(In thousands, except per share data)
Revenues
Automation and Analytics	$	590,392		$	(3,451	)	$	586,941
Medication Adherence	125,773			—			125,773
Gross profit
Automation and Analytics	281,949			(3,451		)	278,498
Medication Adherence	40,139			—			40,139
Selling, general, and administrative expenses	250,312			(8,842		)	241,470
Provision for (benefit from) income taxes	(21,484		)	(4,522		)	(26,006		)
Net income	$	20,605		$	9,913		$	30,518
Net income per share - basic	$	0.55		$	0.26		$	0.81
Net income per share - diluted	$	0.53		$	0.26		$	0.79

	Year Ended December 31, 2016
	As Reported			Adjustment			As Adjusted
	(In thousands, except per share data)
Revenues
Automation and Analytics	$	593,626		$	3,285		$	596,911
Medication Adherence	98,997			—			98,997
Gross profit
Automation and Analytics	282,659			3,285			285,944
Medication Adherence	31,141			—			31,141
Selling, general, and administrative expenses	249,520			(11,639		)	237,881
Provision for (benefit from) income taxes	(2,551		)	5,771			3,220
Net income	$	603		$	9,153		$	9,756
Net income per share - basic	$	0.02		$	0.25		$	0.27
Net income per share - diluted	$	0.02		$	0.24		$	0.26

	December 31, 2017
	As Reported		Adjustment			As Adjusted
	(In thousands)
Accounts receivable and unbilled receivables, net	$	189,227	$	819		$	190,046
Prepaid expenses	36,060		(15,668		)	20,392
Prepaid commissions	—		41,432			41,432
Other long-term assets	39,841		9,475			49,316
Deferred revenues, net	86,104		(7,330		)	78,774
Long-term, deferred revenues	17,244		(6,621		)	10,623
Long-term, deferred tax liabilities	28,579		12,867			41,446
Stockholders’ equity	517,199		37,142			554,341